These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 22104462)

  • 1. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare costs and nonadherence among chronic opioid users.
    Leider HL; Dhaliwal J; Davis EJ; Kulakodlu M; Buikema AR
    Am J Manag Care; 2011 Jan; 17(1):32-40. PubMed ID: 21348566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine toxicology testing in chronic pain management.
    Cone EJ; Caplan YH
    Postgrad Med; 2009 Jul; 121(4):91-102. PubMed ID: 19641275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
    Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
    Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine drug testing for pain management.
    Magnani B; Kwong T
    Clin Lab Med; 2012 Sep; 32(3):379-90. PubMed ID: 22939297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing co-occurring substance use and pain disorders.
    Miotto K; Kaufman A; Kong A; Jun G; Schwartz J
    Psychiatr Clin North Am; 2012 Jun; 35(2):393-409. PubMed ID: 22640762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The appropriate use of opiates in chronic pain.
    Parker AJ
    J Clin Psychiatry; 2012 Aug; 73(8):e26. PubMed ID: 22967785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of urine drug testing for patients on opioid therapy.
    Pergolizzi J; Pappagallo M; Stauffer J; Gharibo C; Fortner N; De Jesus MN; Brennan MJ; Richmond C; Hussey D;
    Pain Pract; 2010; 10(6):497-507. PubMed ID: 20412503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of urine toxicology in chronic opioid analgesic therapy.
    Compton P
    Pain Manag Nurs; 2007 Dec; 8(4):166-72. PubMed ID: 18036504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
    Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug testing and adherence monitoring in pain management: Oral fluid testing.
    Moore C
    J Opioid Manag; 2015; 11(1):69-75. PubMed ID: 25750167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion.
    McCarberg BH
    Postgrad Med; 2011 Mar; 123(2):119-30. PubMed ID: 21474900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine Spiking in a Pain Medicine Clinic: An Attempt to Simulate Adherence.
    Lee D; Bazydlo LA; Reisfield GM; Goldberger BA
    Pain Med; 2015 Jul; 16(7):1449-51. PubMed ID: 25522892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 45.